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OBJECTIVES Our objective was to test the hypothesis that the ultrasound pulsing interval (PI), microbubble
injection site and microvascular pressure significantly influence the transport of 100-nm
microspheres to muscle through extravasation sites created by the destruction of microbubbles
with ultrasound.
BACKGROUND Microbubbles show promise as targeted drug and gene delivery agents; however, designing
optimal microbubble-based therapies will require an understanding of the factors that
influence the transport of microbubble-delivered, gene-bearing vehicles to tissue.
METHODS Ultrasound at 1 MHz, with a peak negative pressure amplitude of 0.75 MPa, was applied to
microbubbles and 100-nm microspheres in exteriorized rat spinotrapezius muscle. Ultrasound
PIs of 1, 3, 5 and 10 s, arterial microsphere injection times of 10 or 40 s and arterial versus
venous injection sites were tested.
RESULTS Extravasation point creation and microsphere delivery were greatest when the ultrasound PI
was 5 or 10 s. No significant differences in extravasation point creation or microsphere delivery
were observed with arterial versus venous microbubble injection, but a trend toward increased
microsphere delivery with arterial injection may exist. Decreasing the arterial injection time from
40 to 10 s increased microvascular pressure, which, in turn, substantially enhanced microsphere
transport to tissue, without a concomitant increase in the number of extravasation points.
CONCLUSIONS The ultrasound PI and microvascular pressure significantly influence the creation of
extravasation points and the transport of microspheres to tissue. These factors may be
important in designing and optimizing contrast ultrasound-based therapies. (J Am Coll
Cardiol 2002;39:726–31) © 2002 by the American College of Cardiology
The effective delivery of intravascular gene-bearing vehicles
is dependent on site-specific targeting and subsequent
transport of these vehicles across the endothelium. Recent
studies have shown that the destruction of microbubble
contrast agents by ultrasound may represent an effective
means of targeting and transporting genes and growth
factors to tissue (1–6). It has been reported that the
application of ultrasound to intravascular microbubble con-
trast agents creates extravasation points in skeletal muscle
capillaries, and that this effect is dependent on applied
ultrasound power (5,7). These extravasation points permit
the passage of 200- and 500-nm polymer microspheres
(PMs) from the bloodstream into the tissue, and in many
cases, PMs are delivered as far as 200 m from the site of
microbubble destruction (6). These results are consistent
with the hypothesis that applying ultrasound to a region of
interest after the simultaneous injection of microbubbles
and drug- or gene-bearing vehicles that are 500 nm in
diameter will deliver these vehicles deep into the tissue.
The future effectiveness of contrast ultrasound-based
gene and growth factor delivery techniques may, however,
be dependent on a number of factors. The purpose of this
study was to quantify the influence of three of these
factors—the pulsing interval (PI), microbubble injection site
and microvascular pressure—on the creation of extravasa-
tion points, and the subsequent intravascular delivery of 100
nm of PMs to the muscle. These studies were performed in
vivo using a rat spinotrapezius muscle preparation that
allows for simultaneous microscopic visualization and ultra-
sound application to the muscle.
METHODS
All studies were approved by the Animal Research Com-
mittee of the University of Virginia, and conformed to the
“Position of the American Heart Association on Research
Animal Use,” adopted by the Association in November 1984.
Ultrasound experiments. Thirty-six female Sprague-
Dawley rats weighing 254  11 g were anesthetized by an
intramuscular injection of ketamine (80 mg/kg body weight)
and xylazine (8 mg/kg). The left femoral vein and right
carotid artery were cannulated. The right spinotrapezius
muscle was exteriorized and arranged in a rectangular
chamber containing a 1 MHz cylindrically focused, single-
element ultrasound transducer aligned with the muscle
thickness, as previously described (5,6,8). The transducer
(Panametrics, Inc., Waltham, Massachusetts) diameter was
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1.5 in. (3.81 cm), which is approximately the length of the
muscle. The input signal to the transducer was generated by
a digital waveform generator (Tektronix AFG-310) and
amplified by a 55-dB radiofrequency power amplifier (ENI
3100LA, Electronic Navigation Ind., Rochester, New
York). Each ultrasound pulse consisted of 100 consecutive
1-MHz sinusoids of 1 V peak-to-peak amplitude from the
waveform generator. Maximal peak negative pressure was
measured with a needle hydrophone (Specialty Engineering
Associates, model PVDF-Z44-0400, Soquel, California), as
0.75 MPa, and the estimated 6-dB beam width was
1.0 mm. These ultrasound variables yield a mechanical
index (MI) (peak negative pressure/center frequency1/2) of
0.75. The transducer was aligned such that the entire muscle
(500 m thickness) was in the 6-dB focal zone.
Six treatment groups (A through F), summarized in
Table 1, were created. For groups A through E, micro-
bubbles (Optison, Mallinkrodt Inc., St. Louis, Missouri)
and 100-nm PMs (Duke Scientific Inc., Palo Alto, Califor-
nia) were injected simultaneously through the carotid artery.
For group F, PM injection commenced 30 s after micro-
bubble injection to the femoral vein. Ultrasound pulsing
commenced when the PM/microbubble (groups A through
E) or PM (group F) injection was initiated. Microbubbles
(0.4 ml) and PMs (0.3 ml) were diluted to 50% and 63% of
the stock concentration, respectively, using 0.9% saline.
Control experiments consisted of injecting PMs and micro-
bubbles without applying ultrasound (n 2), injecting PMs
and a 5% albumin solution without applying ultrasound (n
 2) or applying ultrasound after injection of PMs and a 5%
albumin solution (n  2).
After ultrasound application, entire muscles were video-
taped at 10 magnification using a macroscope (Zeiss).
Discrete extravasation sites, defined by red blood cells in the
tissue, were counted off-line. Then, entire specimens were
imaged using confocal microscopy (BioRad Microradiance
[Hercules, California] confocal attachment with a Nikon
TE-300 [Image Systems Inc., Columbia, Maryland] in-
verted microscope and 10 Nikon Plan-Fluor objective),
with settings adjusted so that no pixels were saturated. The
same settings were used for observation of each field of view
in every specimen. Gray-scale histograms were obtained and
used to calculate the mean gray-scale level for each specimen
Microvascular pressure measurements. Rats (n 5) were
anesthetized as previously described; the spinotrapezius
muscle was exteriorized; and a servo-nulling system (9) was
used to take pressure measurements. A glass micropipette
with a 2-m tip was inserted into a feed arteriole with
micromanipulators (Narshige, Tokyo, Japan). Pressures
were continuously measured before and throughout 10-s (n 
5) and 40-s (n  4) arterial co-injections of microbubbles and
PMs. No more than two injections were performed per animal,
and the injection order was alternated. Pressure measurements
were analyzed with a Butterworth filter, and the mean pressure
before and during injection was calculated.
Statistics. The PI data were analyzed using one-way anal-
ysis of variance, followed by pairwise comparisons with the
Tukey t test. The injection site and duration, as well as
microvascular pressure data, were compared using the Student
t test. The paired Student t test was used to compare injection
pressures with baseline values. Significance was set at p 0.05.
RESULTS
Figure 1 illustrates the appearance of discrete extravasation
points, as denoted by the presence of red blood cells in the
interstitial space, in treatment group C. Figure 2 depicts
confocal images of PM delivery for the treatment groups
(Fig. 2A–F) and a control group (Fig. 2G) in which
ultrasound was applied during administration of 100 nm of
PMs in a 5% albumin solution.
Ultrasound PI. The effects of PI on 100-nm fluorescent
PM delivery to tissue are illustrated in Figure 2A through
2D, where the results for PIs of 1, 3, 5 and 10 s are shown.
The fluorescence area appears greater with the 3- and 5-s
PIs (Fig. 2B and 2C), as compared with the 1- and 10-s
intervals (Fig. 2A and 2D). Figure 3A illustrates that PM
delivery and extravasation point creation increase when the
PI goes from 1 to 5 s, but they subsequently decrease when
the PI is increased from 5 to 10 s. In Figure 3B, the data in
Figure 3A are normalized to the number of applied ultra-
sound pulses. The purpose is to illustrate, over the course of
an entire experiment, the contribution of each individual
ultrasound pulse. The 5- and 10-s PIs exhibit significant
increases in extravasation point creation, as compared with
Abbreviations and Acronyms
MI  mechanical index
PI  pulsing interval
PM  polymer microsphere
VEGF  vascular endothelial growth factor
Table 1. Treatment Groups
Group n
Microbubble
Injection Site
Polymer Microsphere
Injection Duration (s)
Ultrasound Pulsing
Interval (s)
Number of
Ultrasound Pulses
A 5 Carotid artery 40 1 40
B 5 Carotid artery 40 3 13
C 5 Carotid artery 40 5 8
D 4 Carotid artery 40 10 4
E 5 Carotid artery 10 1 10
F 6 Femoral vein 40 3 13
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the 1-s PI. The 5-s interval is also greater than the 3-s
interval. A significant increase in PM delivery per pulse was
observed for the 5- and 10-s PIs, as compared with the 1-s
interval.
Arterial versus venous microbubble injection.
Fluorescent PM delivery after arterial and venous micro-
bubble injection is illustrated in Figure 2B and 2F, respec-
tively. In each case, ultrasound was applied over a 40-s
duration, and the PI was set to 3 s. Total fluorescence per
unit area appears increased in Figure 2B, as compared with
Figure 2F. In Figure 4, it is evident that the microbubble
injection site had no effect on extravasation points per unit
area. Although the fluorescence intensity was approximately
doubled for arterial microbubble injection, this result is
significant only at p  0.15.
Arterial injection time and microvascular pressure.
Figure 2, A and E, illustrates the significant effect that the
injection duration has on fluorescence PM delivery to tissue,
with the image from the 10-s injection duration (Fig. 2E)
showing a marked enhancement of total fluorescence, as
compared with the 40-s duration (Fig. 2A). The key
characteristic of the 10-s duration image is the wide
dispersion of PMs from individual extravasation points.
Figure 5A demonstrates that, with respect to the number of
created extravasation points, there is no significant differ-
ence between a 10- and 40-s injection duration. The shorter
injection time does, however, yield a significant increase in
the delivery of fluorescent PMs. In Figure 5B, the extrava-
sation point and fluorescence data in Figure 5A are normal-
ized to the number of pulses. Here, a significant increase in
Figure 1. Discrete extravasation points created by the application of
1 MHz ultrasound to microbubbles flowing through skeletal muscle
capillaries. Several extravasation points are highlighted with arrows in B.
The specimen is from treatment group C. The bars indicate 1 mm.
Figure 2. Polymer microspheres that have been delivered to muscle
through extravasation points created by microbubble insonation. Groups
A–F and a control group (G), in which ultrasound was applied to polymer
microspheres (PMs) and a 5% albumin solution, are represented. The PMs
are limited to the intravascular space in control specimens. The treatment
groups are described in Table 1. The bar indicates 200 m.
Figure 3. Bar graphs illustrating the effect of the pulsing interval (PI) on
extravasation point creation and fluorescent polymer microsphere delivery
to muscle. (A) Mean gray-scale level above baseline and the number of
extravasation points per unit surface area after a 40-s arterial injection, as
a function of PI. No significant differences were observed at p  0.05. (B)
Data in part A normalized to the number of applied ultrasound pulses.
*p  0.05 versus 1-s PI. **p  0.05 versus 5-s PI.
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extravasation points per pulse is evident. The PM delivery
per pulse for the 10-s injection duration is almost an order
of magnitude greater than that for the 40-s duration.
Microvascular pressures in the feed arterioles were deter-
mined to gain insight into the arterial injection data
presented in Figure 5. In Figure 6, A and B, the pressure
tracings for 10- and 40-s injections, respectively, are shown.
Arterial injections (especially the 10-s duration) create a
pressure spike that is subsequently damped by myogenic
constriction. After the injections, pressures remain below
baseline due to a sustained myogenic response. Figure 6C
depicts the mean pressure increases for the 10- and 40-s
injection durations. The pressure increase above baseline
was significantly greater for the 10-s group, as compared
with the 40-s group.
Control groups. For each control group, no extravasation
points were created, and fluorescence was only observed
inside the vessels. The intravascular fluorescence intensity
was identical for each control group. Gray-scale level data
for treatment groups A through F were found by subtracting
the mean gray-scale level from that of the control speci-
mens.
DISCUSSION
Gene delivery to tissue through microbubble destruction
with targeted ultrasound represents a promising new treat-
ment strategy that may be applicable to a number of
diseases. Although a number of recent studies have demon-
strated “proof of principle” for growth factor and gene
delivery (1–4), optimization of these strategies will require a
better understanding of the unique transport of therapeutic
agents that occurs with these techniques. In this study, we
present evidence that the PI, microvascular pressure and,
possibly, microbubble injection site play an important role
in governing the transport of PMs to tissue by microbubble
destruction with ultrasound.
Factors influencing extravasation point creation and
microsphere transport to tissue. A PI 5 s generates the
greatest PM delivery to rat skeletal muscle. This is because
a PI 5 s does not allow for microbubble concentration
restoration, and a PI 5 s, while delivering the same
number of PMs per pulse, requires a greater time to
generate the same total effect. In practice, a technique
similar to that used for measuring blood flow with contrast
ultrasound (10), wherein video intensity is quantified as a
function of PI, may be used to find the shortest PI at which
the microbubble concentration is restored. In a recent study,
ultrasound with a 3-s interval was used for gene delivery to
the myocardium through microbubbles (1). LacZ expression
appeared to be quite uniform with this PI. When vascular
endothelial growth factor (VEGF) was delivered to the
myocardium with constant ultrasound application (3), it was
noted that VEGF deposition occurred primarily in the
arterioles. Although there are many potential reasons for
this, it is possible that with constant ultrasound application,
VEGF was delivered before reaching the downstream cap-
illaries and venules.
Extravasation point creation by microbubble insonation,
although not well understood, is certainly influenced by a
Figure 4. Bar graph illustrating the effect of arterial versus venous micro-
bubble injection on extravasation point creation and fluorescent polymer
microsphere delivery to the muscle. No significant differences were ob-
served between the groups.
Figure 5. Bar graphs illustrating the effect of arterial injection time on
extravasation point creation and fluorescent polymer microsphere delivery
to the muscle. (A) Mean gray-scale level above baseline and the number of
extravasation points per unit surface area for 10- and 40-s arterial injection
durations. (B) Data in part A normalized to the total number of applied
ultrasound pulses. *p  0.05 versus 40-s injection group.
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number of factors. Because extravasation points are created
only in vessels in which microbubbles are physically con-
strained, the size of the microbubble relative to the mi-
crovessel lumen is clearly important. Our study addressed
this issue by comparing PM delivery with arterially injected
microbubbles with venously injected microbubbles. With
venous injection, large microbubbles are filtered in the lungs
before reaching the muscle. Arterial injections were made
upstream of the muscle; thus, they contained these larger
microbubbles. Arterial and venous injections created the
same total number of extravasation points (Fig. 4); however,
PM delivery with arterial injection was approximately two-
fold greater. Although this result is significant only at p 
0.15, it may indicate that arterial microbubble injections
create extravasation points that are larger and permit greater
delivery vehicle transport. Venous injections are preferable
because of low invasiveness; however, further study of the
potential benefits of arterial microbubble injection is war-
ranted.
The effects of microvascular pressure on PM delivery are
addressed in Figures 5 and 6. In Figure 5A, 10- and 40-s
injections create an equivalent number of extravasation
points, because the same number of microbubbles are
injected for each case. The 10-s duration yields a four times
higher microbubble concentration; however, this is exactly
balanced by the fourfold increase in ultrasound pulses for
the 40-s injection. Given that the same number of extrav-
asation points are created, the doubling of PM delivery with
the 10-s injection (Fig. 5A) must be due to increased
pressure. Microvascular pressure increases 8% during a
10-s injection and decreases 4% during a 40-s injection
(Fig. 6C), yielding a total change of 12%. If resistance to
interstitial PM flow was constant, PM delivery would be
linearly related to the pressure gradient across the wall, and
an increase of 12% in PM delivery would be seen with the
10-s injection. However, PM delivery is 100% greater
with the 10-s injection (Fig. 5A). This apparent discrepancy
may have two explanations. First, initial pressure spikes
created by the 10-s injection were considerably higher than
the mean pressure, and most PM delivery may have oc-
curred at this time. Second, once exposed to positive
pressures, skeletal muscle hydraulic conductivity increases
exponentially with increasing pressure (11). Thus, after
microbubble destruction, small differences in driving pres-
sure create marked increases in delivery vehicle transport.
Strategies for gene delivery with contrast ultrasound.
Two promising strategies for delivering genes and growth
factors with microbubbles are emerging (1–4). The first
entails ultrasound-targeted destruction of microbubbles that
are directly bound to the molecule. Using this strategy, a
10-fold increase in beta-galactosidase activity in the rat
myocardium has been achieved using albumin microbubbles
bound to a recombinant adenovirus containing the comple-
mentary deoxyribonucleic acid (cDNA) encoding beta-
galactosidase. Skeletal muscle transfection has also been
achieved in rats through the ultrasonic destruction of
cationic lipid microbubbles housing plasmid DNA that
contains the luciferase reporter gene (2), and the deposition
of VEGF in intramyocardial arterioles and antisense oligo-
nucleotides in the kidney has been shown (3,4). A second
strategy, in which the genetic material (1), growth factor
(3) or microsphere (6) is in the blood stream but not bound
to a microbubble, attains delivery after ultrasound/
microbubble microvessel permeabilization. Although our
study reproduces this last strategy, we believe that the
transport characteristics for both strategies may actually be
quite similar.
We make this assertion based on the following argument.
First, we have observed that, after microbubble destruction,
microbubble shell fragments remain on the vessel wall (5).
Thus, it is unlikely that the previously reported delivery of
genes to tissue (1,2) was due to microbubble fragment
Figure 6. Representative pressure tracings for transverse arterioles before, during and after 10-s (A) and 40-s (B) arterial injections of microbubbles and
PMs. Microvascular pressure increased during injection for both groups, but then fell below baseline immediately after injection. (C) Bar graph showing
the mean pressure increase above baseline during injection in feed arterioles. *p  0.05 versus 40-s injection group. **p  0.05 versus baseline.
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transport. Instead, when microbubbles with bound genetic
material are destroyed, the genetic material is released from
the microbubbles into the bloodstream (4). Subsequently,
this genetic material would be transported through vessels
permeabilized by the effect of ultrasound on other micro-
bubbles. If this is correct, the basic transport is similar, and
our results are applicable to both strategies.
Ultrasound power, frequency and capillary rupturing.
The potential for clinical contrast ultrasound to create
capillary ruptures in intact organs is controversial. We
previously observed capillary rupturing in exteriorized rat
skeletal muscle with 2.3-MHz ultrasound and intravenously
injected microbubbles (5,6). However, at this frequency, we
cannot reproduce capillary rupturing in intact rat muscle
(R. J. Price, unpublished observations, 2000). Thus, in our
laboratory, muscle exteriorization facilitates capillary rup-
turing at clinical frequencies, perhaps because tissue atten-
uation of ultrasound power is virtually eliminated. In pre-
liminary studies, capillary rupturing was observed in intact
muscle with 1-MHz ultrasound at an MI of 0.75 and with
venous microbubble injection (R. J. Price, unpublished
observations, 2000). Therefore, these values were main-
tained for the current study. Moreover, the ability of
subclinical frequencies (1 MHz) to disrupt the capillary
endothelium and underlying basement membrane in the
presence of microbubbles has been documented by other
investigators (3,12,13). Independently, capillary rupturing
with ultrasound at a clinical frequency (2.5 MHz) has been
shown in the intact diaphragm muscle (7). However, this
study was done in the mouse, whose capillary diameters may
be smaller than those of rats and humans. Precise measure-
ments of the capillary diameter are difficult, and to the best
of our knowledge, they have not been made for mouse
skeletal muscle. However, it is known that the mean
corpuscular volume in mice is significantly less than that in
rats and humans (14), perhaps indicating that capillary
diameters are also smaller. This may be important because,
as previously noted, the relative size of the microbubbles to
the capillary lumen largely determines whether a rupture
will occur. This factor should be considered when extrapo-
lating the results of small animal studies to humans.
Given the current uncertainty surrounding contrast
ultrasound-generated bioeffects, further studies quantifying
microvessel permeability, as a function of ultrasound fre-
quency and power, will be needed to optimize targeted
delivery to intact organs. Based on our observations, ultra-
sound at clinical frequencies does not create the capillary
rupturing bioeffect in intact tissues. Therefore, it seems
likely that specially designed ultrasound transducers will be
required for this purpose. Moreover, the effects of tissue
attenuation and target depth on capillary rupturing must be
studied before precise targeting can be achieved. This
information can be derived from experiments that correlate
the depth of capillary rupturing within a target organ to
selected ultrasound variables.
Conclusions. Our results indicate that extravasation point
creation and PM delivery are greatest when the PI is 5 s.
No significant differences in extravasation point creation or
PM delivery were observed with arterial versus venous
microbubble injection. However, a trend in the data indi-
cates that extravasation points created by arterially injected
microbubbles may allow for greater transport of 100-nm
PMs to tissue. Increasing the convective driving pressure by
decreasing the injection time substantially enhances 100-nm
PM transport to tissue, without a concomitant increase in
extravasation points. We conclude that the PI and micro-
vascular pressure may be important factors in designing and
optimizing future contrast ultrasound-based therapies; how-
ever, further studies on the effects of arterial versus venous
microbubble injection are warranted.
Reprint requests and correspondence: Dr. Richard J. Price,
Department of Biomedical Engineering, University of Virginia,
Box 800759, Health System, Charlottesville, Virginia 22908.
E-mail: rprice@virginia.edu.
REFERENCES
1. Shohet RV, Chen S, Zhou Y-T, et al. Echocardiographic destruction
of albumin microbubbles directs gene delivery to the myocardium.
Circulation 2000;101:2554–6.
2. Christiansen JP, Matsumura M, French B, Klibanov A, Kaul S,
Lindner JR. Transfection of plasmid DNA in skeletal muscle with
ultrasound and cationic microbubble vehicles (abstr). J Am Soc
Echocardiogr 2001;14:426.
3. Mukherjee D, Wong J, Griffin B, et al. Ten-fold augmentation of
endothelial uptake of vascular endothelial growth factor with ultrasound
after systemic administration. J Am Coll Cardiol 2000;35:1678–86.
4. Porter TR, Iversen PL, Li S, Xie F. Interaction of diagnostic
ultrasound with synthetic oligonucleotide-labeled perfluorocarbon-
exposed sonicated dextrose albumin microbubbles. J Ultrasound Med
1996;15:577–84.
5. Skyba DM, Price RJ, Linka AZ, Skalak TC, Kaul S. Direct in vivo
visualization of intravascular destruction of microbubbles by ultra-
sound and its local effects on tissue. Circulation 1998;98:290–3.
6. Price RJ, Skyba DM, Kaul S, Skalak TC. Delivery of colloidal particles
and red blood cells to tissue through microvessel ruptures created by
targeted microbubble destruction with ultrasound. Circulation 1998;
98:1264–7.
7. Miller DL, Quddus J. Diagnostic ultrasound activation of contrast
agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci
USA 2000;97:10179–84.
8. Linka AZ, Skyba DM, Price RJ, Wei K, Skalak TC, Kaul S.
Spontaneous redistribution after reperfusion: a unique property of AIP
201, an ultrasonic contrast agent. J Am Coll Cardiol 1998;32:1765–72.
9. Intaglietta M, Pawula RF, Tompkins WR. Pressure measurements in
the mammalian microvasculature. Microvasc Res 1970;2:212–20.
10. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S.
Ultrasound-induced destruction of intravenously administered micro-
bubbles: a novel method for the quantification of myocardial blood
flow with echocardiography. Circulation 1998;97:473–83.
11. Guyton AC, Scheel K, Murphree D. Interstitial fluid pressure. III. Its
effect on resistance to tissue fluid mobility. Circ Res 1966;19:412–9.
12. Miller DL, Gies RA. Gas-body-based contrast agent enhances vascu-
lar bioeffects of 1.09 MHz ultrasound on mouse intestine. Ultrasound
Med Biol 1998;24:1201–8.
13. Miller DL, Gies RA. The influence of ultrasound frequency and
gas-body composition on the contrast agent-mediated enhancement of
vascular bioeffects in mouse intestine. Ultrasound Med Biol 2000;26:
307–13.
14. Chen D, Kaul DK. Rheologic and hemodynamic characteristics of red
cells of mouse, rat, and human. Biorheology 1994;31:103–13.
731JACC Vol. 39, No. 4, 2002 Song et al.
February 20, 2002:726–31 Microsphere Delivery by Microbubble Insonation
